Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea
· Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
KOSDAQ:175250 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Aug '25 Aug 4, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 81,092 | 81,092 | 67,826 | 78,103 | 79,498 | 338,828 | |
| Market Cap Growth | -2.03% | 19.56% | -13.16% | -1.75% | -76.54% | -27.50% | |
| Enterprise Value | 115,356 | 116,156 | 86,382 | 142,444 | 141,972 | 399,730 | |
| Last Close Price | 2170.00 | 2170.00 | 1815.00 | 2090.00 | 2555.00 | 13038.48 | |
| PE Ratio | - | - | 56.63 | - | - | - | |
| Forward PE | - | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | |
| PS Ratio | 0.97 | 0.97 | 1.34 | 1.38 | 1.34 | 5.27 | |
| PB Ratio | 2.95 | 2.95 | 1.10 | 1.30 | 0.87 | 3.43 | |
| P/TBV Ratio | 3.13 | 3.13 | 1.23 | 1.53 | 0.95 | 3.83 | |
| EV/Sales Ratio | 1.38 | 1.39 | 1.70 | 2.51 | 2.39 | 6.22 | |
| Debt / Equity Ratio | 1.00 | 1.00 | 0.66 | 1.23 | 0.95 | 0.75 | |
| Net Debt / Equity Ratio | 0.61 | 0.61 | 0.29 | 1.09 | 0.36 | 0.50 | |
| Net Debt / EBITDA Ratio | -1.44 | -1.44 | -2.51 | -3.53 | -1.76 | -2.23 | |
| Net Debt / FCF Ratio | -2.13 | -2.13 | -0.94 | -4.16 | -2.15 | -1.56 | |
| Asset Turnover | 0.74 | 0.74 | 0.34 | 0.29 | 0.27 | 0.31 | |
| Inventory Turnover | 7.24 | 7.24 | 3.40 | 4.71 | 4.72 | 4.75 | |
| Quick Ratio | 0.44 | 0.44 | 0.53 | 0.18 | 0.57 | 0.66 | |
| Current Ratio | 0.62 | 0.62 | 0.76 | 0.33 | 0.73 | 1.07 | |
| Return on Equity (ROE) | -79.17% | -79.17% | 5.76% | -42.30% | -44.66% | -35.97% | |
| Return on Assets (ROA) | -10.22% | -10.22% | -6.64% | -8.83% | -7.70% | -9.17% | |
| Return on Invested Capital (ROIC) | -29.24% | -29.60% | -15.56% | -22.02% | -19.80% | -19.54% | |
| Return on Capital Employed (ROCE) | -52.30% | -52.30% | -23.00% | -37.40% | -23.70% | -18.80% | |
| Earnings Yield | -41.43% | -41.43% | 1.77% | -40.04% | -52.54% | -11.26% | |
| FCF Yield | -9.61% | -9.61% | -28.13% | -20.16% | -19.47% | -9.42% | |
| Buyback Yield / Dilution | -0.09% | -0.09% | 0.35% | -61.23% | -7.58% | -9.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.